CRISPR: New Chapter in Gene Editing or a Bane?
Over the past few decades, researchers and investors have pinned their hopes on experimental gene therapies to change the landscape of disease and treatments. The most recent addition to the list: Clustered regularly-inter spaced short palindromic repeats (CRISPR), a powerful gene-editing technique that allows researchers to cut-and-paste genes and thereby altering the medical landscape with the way we are treated with medicines. CRISPR is still a long way from emerging as a one stop shop to stem disease-causing mutations from human cells. Newsclick interviews Dr. Satyajit Rath of the National Institute of Immunology about the latest technology on the block and its potentials and implications.